Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
23,950
+500 (2.13%)
Mar 12, 2026, 9:29 AM KST
Market Cap160.29B +47.9%
Revenue (ttm)66.51B -10.3%
Net Income2.32B
EPS340.76
Shares Out6.97M
PE Ratio67.50
Forward PEn/a
Dividend1,200.00 (5.51%)
Ex-Dividend DateDec 29, 2025
Volume942
Average Volume23,379
Open23,350
Previous Close23,450
Day's Range23,350 - 23,950
52-Week Range14,500 - 31,450
Beta-0.28
RSI49.84
Earnings DateFeb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements